Loading...
Retractable Technologies, Inc.
RVP•AMEX
Healthcare
Medical - Instruments & Supplies
$0.71
$0.002(0.27%)
Retractable Technologies, Inc. (RVP) Financial Performance & Income Statement Overview
Review Retractable Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-24.19%
↓ 24.19%
Operating Income Growth
-83.72%
↓ 83.72%
Net Income Growth
-69.54%
↓ 69.54%
Operating Cash Flow Growth
-517.70%
↓ 517.70%
Operating Margin
-89.57%
↓ 89.57%
Gross Margin
-11.52%
↓ 11.52%
Net Profit Margin
-89.65%
↓ 89.65%
ROE
-27.43%
↓ 27.43%
ROIC
-16.31%
↓ 16.31%
Retractable Technologies, Inc. (RVP) Income Statement & Financial Overview
Review Retractable Technologies, Inc.'s (RVP) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $9.07M | $10.35M | $6.03M |
| Cost of Revenue | $0.00 | $11.57M | $10.36M | $6.45M |
| Gross Profit | -$1911.00 | -$2.49M | -$14810.00 | -$419924.00 |
| Gross Profit Ratio | -$0.27 | -$0.001 | -$0.07 | |
| R&D Expenses | $191192.00 | $157894.00 | $174695.00 | $199093.00 |
| SG&A Expenses | $4.48M | $4.57M | $4.95M | $5.14M |
| Operating Expenses | $4.67M | $4.73M | $5.12M | $5.34M |
| Total Costs & Expenses | $0.00 | $16.29M | $15.48M | $11.79M |
| Interest Income | $0.00 | $145041.00 | $293550.00 | $244518.00 |
| Interest Expense | -$23455.00 | $26711.00 | $30489.00 | $31817.00 |
| Depreciation & Amortization | $0.00 | $1.89M | $1.91M | $1.89M |
| EBITDA | -$4.68M | $5.69M | -$15877.00 | -$3.94M |
| EBITDA Ratio | $0.63 | -$0.002 | -$0.65 | |
| Operating Income | -$4.68M | -$7.22M | -$5.14M | -$5.76M |
| Operating Income Ratio | -$0.80 | -$0.50 | -$0.96 | |
| Other Income/Expenses (Net) | -$5.54M | $10.99M | $3.18M | -$92038.00 |
| Income Before Tax | -$10.21M | $3.77M | -$1.95M | -$5.85M |
| Income Before Tax Ratio | $0.42 | -$0.19 | -$0.97 | |
| Income Tax Expense | $285761.00 | $1990.00 | -$31181.00 | $8.31M |
| Net Income | -$10.50M | $3.77M | -$1.92M | -$14.16M |
| Net Income Ratio | $0.42 | -$0.19 | -$2.35 | |
| EPS | -$0.35 | $0.13 | -$0.07 | -$0.48 |
| Diluted EPS | -$0.35 | $0.13 | -$0.07 | -$0.48 |
| Weighted Avg Shares Outstanding | $29.94M | $29.94M | $29.94M | $29.94M |
| Weighted Avg Shares Outstanding (Diluted) | $29.94M | $29.94M | $29.94M | $29.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan